- Min.Order :1 Gram
- Purity: >98%
- Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other
Keywords
ACOMPLIA,SR141716 98% high purity manufacture Rimonabant
Quick Details
- Appearance:white powder
- Application:cannabinoid-1，CB1,168273-06-1
- PackAge:1g;5g
- ProductionCapacity:100|Gram|Quarter
- Storage:0-25℃;away from light
- Transportation:by sea or air or express delivery
Superiority:
Best service,high quality and reasonable price,COA
1.High quality : the purity is 98% min . through multiple producing procedures.
2.Competitive price : low price because of our skilled production technolpgy ,save the production cost at most , and give big profit room to our customers
3.Safe and fast delivery : we have professional shipment team for each package , the best shipping lines , each package can reach safe ly and fastly .
4.Varied shipment methods : We can ship via EMS , HKEMS ,FEDEX ,DHL ,TNT,UPS for small packages (from 1g to 1kg), and by air or by sea for big quantity . Once ship out , there is a tracking number for your package , you can follow it online, more convenient
5.Good service : 1g order or 1kg order , we will treat as the same . thinking of all possible problems for the customer ,giving the best suggestions , and good professional guide for the products
Details:
roduct Name: Rimonabant
Synonyms: ACOMPLIA;RIMONABANT;RIMONABANT(ACOMPLIA,SR141716);5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide;1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-;5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide;A 281;Sr 141716
CAS: 168273-06-1
MF: C22H21Cl3N4O
MW: 463.79
EINECS:
Product Categories: Weight Loss;SR141716
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View